Literature DB >> 15766751

BMP4 and noggin control embryonic blood vessel formation by antagonistic regulation of VEGFR-2 (Quek1) expression.

Suresh Nimmagadda1, Poongodi Geetha Loganathan, Ruijin Huang, Martin Scaal, Corina Schmidt, Bodo Christ.   

Abstract

Regulation of VEGFR-2 (Quek1) is an important mechanism during blood vessel formation. In the paraxial mesoderm, Quek1 expression is restricted to the lateral portion of the somite and later to sclerotomal cells surrounding the neural tube. By grafting of either intermediate mesoderm or BMP4 beads into the paraxial mesoderm, we show that BMP4 is a positive regulator of VEGFR-2 (Quek1) expression in the quail embryo. Separation of somites from intermediate mesoderm leads to down-regulation of Quek1 expression. The expression of Quek1 in the medial somite half is normally repressed by the notochord and becomes up-regulated and lateromedially expanded after separation of the notochord. Our results show that up-regulation of BMP4 leads to an increase of the number of blood vessels, whereas inhibition of BMP4 by noggin results in a reduction of blood vessels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15766751     DOI: 10.1016/j.ydbio.2005.01.005

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  22 in total

1.  An anteroposterior wave of vascular inhibitor downregulation signals aortae fusion along the embryonic midline axis.

Authors:  Robert J Garriock; Catherine Czeisler; Yasuo Ishii; Alicia M Navetta; Takashi Mikawa
Journal:  Development       Date:  2010-11       Impact factor: 6.868

Review 2.  Bone Morphogenetic Protein functions as a context-dependent angiogenic cue in vertebrates.

Authors:  David M Wiley; Suk-Won Jin
Journal:  Semin Cell Dev Biol       Date:  2011-10-12       Impact factor: 7.727

3.  Enhancement of human adipose-derived stromal cell angiogenesis through knockdown of a BMP-2 inhibitor.

Authors:  Benjamin Levi; Emily R Nelson; Jeong S Hyun; Jason P Glotzbach; Shuli Li; Allison Nauta; Daniel T Montoro; Min Lee; George C Commons; Shijun Hu; Joseph C Wu; Geoffrey C Gurtner; Michael T Longaker
Journal:  Plast Reconstr Surg       Date:  2012-01       Impact factor: 4.730

4.  Shaping Waves of Bone Morphogenetic Protein Inhibition During Vascular Growth.

Authors:  Pierre J Guihard; Yina Guo; Xiuju Wu; Lily Zhang; Jiayi Yao; Medet Jumabay; Yucheng Yao; Alan Garfinkel; Kristina I Boström
Journal:  Circ Res       Date:  2020-08-28       Impact factor: 17.367

5.  Temporal sequence in the formation of midline dermis and dorsal vertebral elements in avian embryos.

Authors:  Qin Pu; Bodo Christ; Ruijin Huang
Journal:  J Anat       Date:  2012-05-21       Impact factor: 2.610

6.  Orthotopic expression of noggin protein in cancer cells inhibits human lung carcinoma growth in vivo.

Authors:  Hye-Won Kang; Suresh Gupta; Alexei Bogdanov
Journal:  Mol Imaging Biol       Date:  2012-08       Impact factor: 3.488

7.  Promotion of avian endothelial cell differentiation by GATA transcription factors.

Authors:  Caramai N Kamei; Hervé Kempf; Ronit Yelin; Georges Daoud; Richard G James; Andrew B Lassar; Clifford J Tabin; Thomas M Schultheiss
Journal:  Dev Biol       Date:  2011-02-23       Impact factor: 3.582

8.  Notochord-derived BMP antagonists inhibit endothelial cell generation and network formation.

Authors:  Michael Bressan; Patricia Davis; John Timmer; Doris Herzlinger; Takashi Mikawa
Journal:  Dev Biol       Date:  2008-11-12       Impact factor: 3.582

9.  In vitro and In vivo imaging of antivasculogenesis induced by Noggin protein expression in human venous endothelial cells.

Authors:  Hye-Won Kang; Ronn Walvick; Alexei Bogdanov
Journal:  FASEB J       Date:  2009-08-19       Impact factor: 5.191

10.  Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells.

Authors:  Anna Csiszar; Nazar Labinskyy; Hanjoong Jo; Praveen Ballabh; Zoltan Ungvari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-06       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.